FULGENT GENETICS, INC. Equity Method Investments
FULGENT GENETICS, INC. (FLGT) had Equity Method Investments of $1.62 million as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2021-03-08
- 2020-09-30: Equity Method Investments $1.62M.
- 2020-06-30: Equity Method Investments $430.00K.
- 2020-03-31: Equity Method Investments $623.00K.
- 2019-12-31: Equity Method Investments $872.00K.
| Period end | Equity Method Investments |
|---|---|
| 2020-09-30 | $1.62M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $430.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $623.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $872.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | $909.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.08M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $1.23M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.51M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.75M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.96M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $1.69M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.94M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.18M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$105.00K 10-Q · filed 2017-08-14 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |